冲刺万亿规模！广东生物制造“三箭齐发”，聚焦非粮利用、美妆原料、三新食品和医疗

Core Viewpoint - Guangdong Province aims to enhance the bio-manufacturing industry, targeting a total output value of approximately 500 billion yuan by 2027 and reaching a trillion yuan scale by 2035, focusing on key areas such as non-grain utilization, medical beauty raw materials, microbial proteins, and green processes in biopharmaceuticals [2][3][4]. Group 1: Policy Measures and Goals - The action plan specifies the development goals for the bio-manufacturing industry in Guangdong, aiming for a total output value of around 500 billion yuan by 2027 and a trillion yuan scale by 2035 [2][3]. - The measures address key bottlenecks in bio-manufacturing, including the need for improved standards and ecosystem development [4][6]. Group 2: Key Initiatives - The policy outlines detailed initiatives to tackle issues such as an incomplete industrial chain and lagging standard system construction, emphasizing the establishment of a comprehensive bio-manufacturing industry standard system [6]. - It encourages the establishment of innovation platforms and supports the construction of transformation bases for innovative achievements, promoting technology transfer and application [6]. Group 3: Focus Areas for Development - The measures focus on core technology breakthroughs, including strains, enzyme preparations, and reactors, as well as high-end platform construction and targeted R&D mechanisms [7]. - The policy emphasizes the importance of building a robust standard system that includes both domestic and international standards, facilitating market access and internationalization [7]. Group 4: Applications in Bio-Manufacturing - The initiative aims to advance non-grain bio-based materials, medical beauty products, and "new food" categories, promoting the use of microbial proteins and plant-based proteins [8][9]. - In the pharmaceutical sector, the policy encourages the application of bio-manufacturing in green process development for biopharmaceuticals and the synthesis of effective components from traditional Chinese medicine [9]. Group 5: Internationalization Strategies - The policy outlines strategies for internationalization, including aligning with international standards organizations and expanding overseas markets through e-commerce and overseas warehouses [10]. - It emphasizes the importance of attracting key domestic and international enterprises and high-end R&D institutions to build a global resource collaboration network [10]. Group 6: Regional Development and Innovation - Guangdong Province implements a "dual-core drive" strategy, focusing on Guangzhou and Shenzhen to accelerate the development of the bio-manufacturing industry in the Greater Bay Area [11]. - The policy supports the establishment of a comprehensive support system for bio-manufacturing, covering research, pilot testing, and industrialization [11].